文献速递美容整形乳房整形与再造创面修复

用于预测术后出院阿片类药物需求的个性化阿片类药物处方模型

A Personalized Opioid Prescription Model for Predicting Postoperative Discharge Opioid Needs.
PubMed 文献 · Plast Reconstr Surg · 2022-11-15

单中心回顾性队列研究纳入149例整形与重建外科患者,其中116例住院2至8天且可量化阿片类药物消耗者纳入分析,利用术后每日住院阿片类药物消耗量构建个性化对数回归模型预测出院后需求。个性化阿片类药物处方(POP)模型与出院后4周患者自报实际消耗量的关联(R²=0.899;P<0.0001)强于基于术式的模型(R²=0.226;P=0.025)和24小时模型(R²=0.152;P=0.007)。

要点

  • POP模型输出与出院后阿片类药物消耗量关联最强(R²=0.899;P<0.0001)。
  • POP模型准确性不受年龄、性别认同、术式或住院时长影响。
  • 出院后估计阿片需求每增加37.5口服吗啡当量,4周持续使用 odds 为1.16(P=0.010;95%CI 1.04至1.30)。

核心结论

  • POP模型能准确估计整形外科患者出院后阿片类药物消耗量及持续使用风险。
  • 在临床实践中使用POP模型可能促成更适当和个性化的阿片类药物处方。

研究设计与样本

  • 单中心回顾性队列研究,评估149例整形与重建外科患者。
  • 纳入住院时长2至8天且可量化住院阿片类药物消耗的患者共116例。
  • 利用每例患者术后每日住院阿片类药物消耗量生成个性化对数回归模型以估计出院后阿片需求。
  • 通过比较术后4周患者自报实际出院后阿片类药物消耗量检验POP模型有效性,并与另外两种阿片处方模型比较准确性。

主要发现

  • POP模型输出与出院后阿片类药物消耗量的关联最强(R²=0.899;P<0.0001),优于基于术式的模型(R²=0.226;P=0.025)和24小时模型(R²=0.152;P=0.007)。
  • POP模型的准确性不受年龄、性别认同、术式或住院时长影响。
  • 4周持续使用的 odds 随出院后估计阿片需求增加而升高,速率为每37.5口服吗啡当量1.16(P=0.010;95%CI 1.04至1.30)。

关键数值与推荐

  • POP模型与出院后阿片消耗关联R²=0.899(P<0.0001)。
  • 基于术式模型R²=0.226(P=0.025)。
  • 24小时模型R²=0.152(P=0.007)。
  • 4周持续使用 odds 为每37.5口服吗啡当量1.16(P=0.010;95%CI 1.04至1.30)。

临床怎么用

  • 作者认为,在临床实践中使用POP模型可能促成更适当和个性化的阿片类药物处方。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Opioid overprescribing after surgery is common. There is currently no universal predictive tool available to accurately anticipate postdischarge opioid need in a patient-specific manner. This study examined the efficacy of a patient-specific opioid prescribing framework for estimating postdischarge opioid consumption. METHODS: A total of 149 patients were evaluated for a single-center retrospective cohort study of plastic and reconstructive surgery patients. Patients with length of stay of 2 to 8 days and quantifiable inpatient opioid consumption (n = 116) were included. Each patient's daily postoperative inpatient opioid consumption was used to generate a personalized logarithmic regression model to estimate postdischarge opioid need. The validity of the personalized opioid prescription (POP) model was tested through comparison with actual postdischarge opioid consumption reported by patients 4 weeks after surgery. The accuracy of the POP model was compared with two other opioid prescribing models. RESULTS: The POP model had the strongest association (R2 = 0.899; P < 0.0001) between model output and postdischarge opioid consumption when compared to a procedure-based (R2 = 0.226; P = 0.025) or a 24-hour (R2 = 0.152; P = 0.007) model. Accuracy of the POP model was unaffected by age, gender identity, procedure type, or length of stay. Odds of persistent use at 4 weeks increased, with a postdischarge estimated opioid need at a rate of 1.16 per 37.5 oral morphine equivalents (P = 0.010; 95% CI, 1.04 to 1.30). CONCLUSIONS: The POP model accurately estimates postdischarge opioid consumption and risk of developing persistent use in plastic surgery patients. Use of the POP model in clinical practice may lead to more appropriate and personalized opioid prescribing.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Zhang KK, Blum KM, Chu JJ, et al. A Personalized Opioid Prescription Model for Predicting Postoperative Discharge Opioid Needs. Plast Reconstr Surg. 2022. PMID: 36696335. doi:10.1097/PRS.0000000000009865

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。